Arbutus Biopharma Corporation
DE ˙ DB ˙ CA03879J1003
3,67 € ↓ -0,12 (-3,17%)
2026-06-03
DEL PRIS
SecurityDE:I9DN / Arbutus Biopharma Corporation
InstitutionBarclays Plc
Latest Disclosed Ownership356,684 shares
Latest Disclosed Value $ 1,715,650
Barclays Plc ownership in I9DN / Arbutus Biopharma Corporation

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 356,684 shares of Arbutus Biopharma Corporation (DE:I9DN) valued at $1,398,915 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 284,330 shares of Arbutus Biopharma Corporation. This represents a change in shares of 25.45% during the quarter. The current value of the position is $1,309,030 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (I9DN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:I9DN / Arbutus Biopharma Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 356,684 72,354 25.45 1,716 32.95 0.0004
2026-03-31 2025-09-30 13F/A-3 ARBUTUS BIOPHARMA COM 03879J100 284,330 -122,228 -30.06 1,291 2.71 0.0003
2026-03-19 2025-09-30 13F/A-2 ARBUTUS BIOPHARMA COM 03879J100 272,029 -134,529 1,047 0.0003
2025-11-12 2025-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 284,330 -122,228 1,291 0.0003
2026-02-27 2025-06-30 13F/A-2 ARBUTUS BIOPHARMA COM 03879J100 406,558 180,393 79.76 1,256 59.19 0.0003
2025-08-14 2025-06-30 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 406,558 180,393 1 0.0003
2025-08-13 2025-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 406,558 180,393 1 0.0001
2026-03-17 2025-03-31 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 226,165 -72,088 -24.17 789 -19.08 0.0002
2025-05-15 2025-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 226,165 -72,088 1 0.0002
2026-03-19 2024-12-31 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 298,253 26,224 9.64 975 -6.88 0.0003
2025-02-13 2024-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 298,253 26,224 1 0.0003
2026-03-31 2024-09-30 13F/A-2 ARBUTUS BIOPHARMA COM 03879J100 272,029 223,995 466.33 1,047 607.43 0.0003
2024-11-19 2024-09-30 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 272,029 223,995 1 0.0003
2024-11-15 2024-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 272,029 223,995 1 0.0001
2026-03-23 2024-06-30 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 48,034 -41,152 -46.14 148 -35.65 0.0000
2024-08-14 2024-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 48,034 -41,152 0 0.0000
2026-03-24 2024-03-31 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 89,186 -126,757 -58.70 230 -57.33 0.0001
2024-05-15 2024-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 89,186 -126,757 0 0.0001
2026-03-25 2023-12-31 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 215,943 84,098 63.79 540 101.87 0.0002
2024-02-15 2023-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 215,943 84,098 1 0.0002
2026-03-26 2023-09-30 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 131,845 83,950 175.28 268 142.73 0.0002
2023-11-07 2023-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 131,845 83,950 0 0.0002
2026-03-30 2023-06-30 13F/A-2 ARBUTUS BIOPHARMA COM 03879J100 47,895 -9,663 -16.79 110 -36.78 0.0001
2023-09-20 2023-06-30 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 47,895 -9,663 0 0.0001
2023-08-03 2023-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 47,895 -9,663 0 0.0001
2026-03-30 2023-03-31 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 57,558 27,054 88.69 174 145.07 0.0001
2023-05-04 2023-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 57,558 27,054 0 0.0001
2026-03-30 2022-12-31 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 30,504 25,925 566.17 71 688.89 0.0000
2023-02-13 2022-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 30,504 25,925 0 0.0000
2022-11-03 2022-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 4,579 -841 -15.52 9 -40.00 0.0000
2022-08-12 2022-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 5,420 -329,376 -98.38 15 -98.50 0.0000
2022-05-16 2022-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 334,796 63,342 23.33 997 -5.50 0.0008
2022-02-23 2021-12-31 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 271,454 -364,002 -57.28 1,055 -61.30 0.0004
2022-02-14 2021-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 271,454 -364,002 1,055 0.0004
2021-11-09 2021-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 635,456 625,543 6,310.33 2,726 8,986.67 0.0012
2021-08-13 2021-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 9,913 -92,956 -90.36 30 -91.23 0.0000
2021-05-13 2021-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 102,869 102,478 26,209.21 342 34,100.00 0.0002
2021-02-11 2020-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 391 391 1 0.0000
2020-05-13 2020-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 0 -360 -100.00 0 -100.00
2020-02-10 2019-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 360 -723 -66.76 1 -50.00 0.0000
2019-11-15 2019-09-30 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 1,083 -73,165 -98.54 2 -98.71 0.0000
2019-11-14 2019-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 1,083 -73,165 2 0.4624
2019-08-14 2019-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 74,248 59,103 390.25 155 187.04 0.0001
2019-05-15 2019-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 15,145 2,580 20.53 54 12.50 0.0000
2019-02-14 2018-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 12,565 -1,204 -8.74 48 -63.08 0.0000
2018-11-14 2018-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 13,769 11,177 431.21 130 584.21 0.0001
2018-08-14 2018-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 2,592 2,460 1,863.64 19 1,800.00 0.0000
2018-05-15 2018-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 132 -72,669 -99.82 1 -99.73 0.0000
2018-02-14 2017-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 72,801 -2,940 -3.88 368 -21.70 0.0003
2017-11-14 2017-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 75,741 2,941 4.04 470 79.39 0.0005
2017-08-14 2017-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 72,800 0 0.00 262 10.55 0.0003
2017-05-15 2017-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 72,800 72,800 237 0.0003
2016-02-12 2015-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 0 -1 -100.00 0 0.0000
2015-11-13 2015-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 1 1 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-03-24 2024-03-31 13F/A ARBUTUS BIOPHARMA OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ARBUTUS BIOPHARMA OPT Call 0 0 n/a n/a n/a
2026-03-25 2023-12-31 13F/A ARBUTUS BIOPHARMA OPT Call 75,000 188 n/a n/a n/a
2024-02-15 2023-12-31 13F ARBUTUS BIOPHARMA OPT Call 75,000 0 n/a n/a n/a
2018-11-14 2018-09-30 13F ARBUTUS BIOPHARMA OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F ARBUTUS BIOPHARMA OPT Call 75,000 0.00 548 46.13 n/a n/a n/a
2018-05-15 2018-03-31 13F ARBUTUS BIOPHARMA OPT Call 75,000 375 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-03-24 2024-03-31 13F/A ARBUTUS BIOPHARMA OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F ARBUTUS BIOPHARMA OPT Put 0 0 n/a n/a n/a
2026-03-25 2023-12-31 13F/A ARBUTUS BIOPHARMA OPT Put 75,000 188 n/a n/a n/a
2024-02-15 2023-12-31 13F ARBUTUS BIOPHARMA OPT Put 75,000 0 n/a n/a n/a
2018-11-14 2018-09-30 13F ARBUTUS BIOPHARMA OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-14 2018-06-30 13F ARBUTUS BIOPHARMA OPT Put 75,000 0.00 548 46.13 n/a n/a n/a
2018-05-15 2018-03-31 13F ARBUTUS BIOPHARMA OPT Put 75,000 375 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.